Abstract
The endogenous insulin sensitizing machinery termed the hepatic insulin sensitizing substance (HISS) mechanism has been shown to be nitrergic and linked to sensory fibers in the anterior hepatic plexus. We studied whether this mechanism could pharmacologically be exploited by cicletanine, a cGMP-PDE inhibitor antihypertensive drug, in conscious rabbits. Whole body insulin sensitivity and peripheral glucose uptake were determined by hyperinsulinaemic euglycaemic glucose clamping, and cardiac radiolabelled deoxyglucose (DOG) uptake in neurogenic, achieved by perineurial capsaicin treatment of the anterior hepatic plexus through defunctionalization of hepatic sensory fibers, and metabolic, induced by dietary hypercholesterolemia, insulin resistance models after single oral doses of cicletanine (3, 10 and 30 mg kg−1) or rosiglitazone (3 mg kg−1). The effect of cicletanine on cardiac and vascular tissue NO, cGMP, cAMP was measured by means of spin trapping technique and radioimmunoassay, respectively. Insulin sensitivity and peripheral DOG uptake were significantly increased by 10 and 30 mg kg−1 cicletanine in both healthy and hypercholesterolaemic rabbits, but not in those with neurogenic insulin resistance. Rosiglitazone had no effect in healthy and neurogenic insulin resistant rabbits although it improved insulin sensitivity in hypercholesterolemic animals. The 10 mg kg−1 cicletanine dose induced no change in either cardiac or vascular tissue NO, cGMP or cAMP concentrations. Nevertheless, at a dose of 30 mg kg−1 producing an insulin sensitizing effect of approximately the same amplitude as seen with 10 mg kg−1, the drug significantly increased tissue NO and cGMP concentrations. Oral cicletanine attains its insulin sensitizing effect at doses lower than those necessary to activate the NO-cGMP pathway in the cardiovascular system. This metabolic effect requires functional integrity of hepatic sensory nerves.
Similar content being viewed by others
Abbreviations
- cAMP:
-
cyclic AMP
- cGMP:
-
cyclic GMP
- PDE:
-
phosphodiestherase
- HISS:
-
hepatic insulin sensitizing substance
- RIST:
-
rapid insulin sensitivity test
References
Akamatsu N, Sawada S, Komatsu S, Tamagaki T, Hiranuma O, Kawahara T, Tsuda Y, Kono Y, Higaki T, Tada Y, Yamasaki S, Imamura H, Sato T, Tsuji H, Nakagawa M (2001) Effect of cicletanine on the nitric oxide pathway in human umbilical vein endothelial cells. J Cardiovasc Pharmacol 38:174–182
Bajza A, Peitl B, Nemeth J, Porszasz R, Rabloczky G, Literati-Nagy P, Szilvassy J, Szilvassy Z (2004) Development of insulin resistance by nitrate tolerance in conscious rabbits. J Cardiovasc Pharmacol 43:471–476
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214–E223
Ebeigbe AB, Cabanie M (1991) In vitro vascular effects of cicletanine in pregnancy-induced hypertension. Br J Pharmacol 103:1992–1996
Freedman SB, Daxini BV, Noyce D, Kelly DT (1995) Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. J Am Coll Cardiol 25:349–355
Kalinowski L, Szczepanska-Konkel M, Jankowski M, Angielski S (1999) Cicletanine: new insights into its pharmacological actions. Gen Pharmacol 33:7–16
Kovacs P, Szilvassy Z, Hegyi P, Nemeth J, Ferdinandy P, Tosaki A (2000) Effect of transdermal nitroglycerin on glucose-stimulated insulin release in healthy male volunteers. Eur J Clin Invest 30:41–44
Lautt WW (1999) The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol 77:553–562
Lautt WW (2003) Practice and principles of pharmacodynamic determination of HISS-dependent and HISS-independent insulin action: methods to quantitate mechanisms of insulin resistance. Med Res Rev 23:1–14
Lautt WW (2004) A new paradigm for diabetes and obesity: the hepatic insulin sensitizing substance (HISS) hypothesis. J Pharmacol Sci 95:9–17
Lautt WW, Wang X, Sadri P, Legare DJ, Macedo MP (1998) Rapid insulin sensitivity test (RIST). Can J Physiol Pharmacol 76:1080–1086
Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109–142
Moore MC, Satake S, Baranowski B, Hsieh PS, Neal DW, Cherrington AD (2002) Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab 282:E286–E296
Parker JD, Parker JO (1998) Nitrate therapy for stable angina pectoris. N Engl J Med 338:520–531
Porszasz R, Legvari G, Nemeth J, Literati PN, Szolcsanyi J, Szilvassy Z (2002) The sensory nitrergic nature of the hepatic insulin sensitizing substance mechanism in conscious rabbits. Eur J Pharmacol 443:211–212
Porszasz R, Legvari G, Pataki T, Szilvassy J, Nemeth J, Kovacs P, Paragh G, Szolcsanyi J, Szilvassy Z (2003) Hepatic insulin sensitizing substance: a novel ‘sensocrine’ mechanism to increase insulin sensitivity in anaesthetized rats. Br J Pharmacol 139:1171–1179
Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA (2003) Cyclic GMP phosphodiesterases and regulation of smooth muscle function. Circ Res 93:280–291
Sadri P, Lautt WW (1999) Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol 277:G101–G108
Szekeres L, Szilvassy Z, Ferdinandy P, Nagy I, Karcsu S, Csati S (1997) Delayed cardiac protection against harmful consequences of stress can be induced in experimental atherosclerosis in rabbits. J Mol Cell Cardiol 29:1977–1983
Szilvassy Z, Jakab I, Bor P, Koltai M, Tarrade T, Esanu A, Braquet PG, Lonovics J (1993) Cicletanine attenuates overdrive pacing-induced global myocardial ischemia in rabbits: possible role of cardiac cyclic nucleotides. Coron Artery Dis 4:443–452
Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M (1994a) Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol 266:H2033–H2041
Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Szilvassy J, Nagy I, Lonovics J, Koltai M (1994b) Loss of preconditioning in rabbits with vascular tolerance to nitroglycerin. Br J Pharmacol 112:999–1001
Szilvassy Z, Ferdinandy P, Szilvassy J, Nagy I, Karcsu S, Lonovics J, Dux L, Koltai M (1995) The loss of pacing-induced preconditioning in atherosclerotic rabbits: role of hypercholesterolaemia. J Mol Cell Cardiol 27:2559–2569
Szilvassy Z, Ferdinandy P, Nagy I, Jakab I, Koltai M (1997) The effect of continuous versus intermittent treatment with transdermal nitroglycerin on pacing-induced preconditioning in conscious rabbits. Br J Pharmacol 121:491–496
Szilvassy Z, Csont T, Pali T, Droy-Lefaix, Ferdinandy P (2001) Nitric oxide, peroxynitrite and cGMP in atherosclerosis-induced hypertension in rabbits: beneficial effects of cicletanine. J Vasc Res 38:39–46
Szilvassy J, Sziklai I, Sari R, Nemeth J, Peitl B, Porszasz R, Lonovics J, Szilvassy Z (2006) Neurogenic insulin resistance in guinea-pigs with cisplatin-induced neuropathy. Eur J Pharmacol 531:217–225
Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1– 9
Acknowledgements
This work was supported by grants from the Hungarian Ministry of Education (OTKA T043467, T046244, D45922) and Ministry of Health (ETT-03597/2003 and ETT-02585/2003, NKFP 3900/0/27/117T/01).
Author information
Authors and Affiliations
Corresponding author
Additional information
Comment: This work was supported by grants from the Hungarian Ministry of Education (OTKA T043467, T046244, D45922) and Ministry of Health (ETT-03597/2003 and ETT-585/2003, NKFP 3900/0/27/117T/01).
Rights and permissions
About this article
Cite this article
Peitl, B., Németh, J., Pankucsi, C. et al. Insulin sensitization induced by oral cicletanine in conscious rabbits. Naunyn-Schmied Arch Pharmacol 373, 429–439 (2006). https://doi.org/10.1007/s00210-006-0096-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-006-0096-8